Bibliography
- 1 Sebat J, Lakshmi B, Troge J et al.: Large-scale copy number polymorphism in the human genome. Science305(5683),525–528 (2004).
- 2 Redon R, Ishikawa S, Fitch KR et al.: Global variation in copy number in the human genome. Nature444(7118),444–454 (2006).
- 3 Iafrate AJ, Feuk L, Rivera MN et al.: Detection of large-scale variation in the human genome. Nat. Genet.36(9),949–951 (2004).
- 4 Shrestha S, Tang J, Kaslow RA: Gene copy number: learning to count past two. Nat. Med.15(10),1127–1129 (2009).
- 5 Wain LV, Armour JA, Tobin MD: Genomic copy number variation, human health, and disease. Lancet374(9686),340–350 (2009).
- 6 Mccarroll SA, Hadnott TN, Perry GH et al.: Common deletion polymorphisms in the human genome. Nat. Genet.38(1),86–92 (2006).
- 7 Hebbring SJ, Adjei AA, Baer JL et al.: Human SULT1A1 gene: copy number differences and functional implications. Hum. Mol. Genet.16(5),463–470 (2007).
- 8 Bolt HM, Thier R: Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology. Curr. Drug Metab.7(6),613–628 (2006).
- 9 Yokoi T, Kamataki T: Genetic polymorphism of drug metabolizing enzymes: new mutations in CYP2D6 and CYP2A6 genes in Japanese. Pharm. Res.15(4),517–524 (1998).
- 10 Bradford LD: CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. Pharmacogenomics3(2),229–243 (2002).
- 11 Ingelman-Sundberg M: Genetic polymorphisms of CYP450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J.5(1),6–13 (2005).
- 12 Aklillu E, Persson I, Bertilsson L, Johansson I, Rodrigues F, Ingelman-Sundberg M: Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles. J. Pharmacol. Exp. Ther.278(1),441–446 (1996).
- 13 Ishiguro A, Kubota T, Ishikawa H, Iga T: Metabolic activity of dextromethorphan O-demethylation in healthy Japanese volunteers carrying duplicated CYP2D6 genes: duplicated allele of CYP2D6*10 does not increase CYP2D6 metabolic activity. Clin. Chim. Acta344(1–2),201–204 (2004).
- 14 Kiyotani K, Shimizu M, Kumai T, Kamataki T, Kobayashi S, Yamazaki H: Limited effects of frequent CYP2D6*36-*10 tandem duplication allele on in vivo dextromethorphan metabolism in a Japanese population. Eur. J. Clin. Pharmacol.66(10),1065–1068 (2010).
- 15 Meijerman I, Sanderson LM, Smits PH, Beijnen JH, Schellens JH: Pharmacogenetic screening of the gene deletion and duplications of CYP2D6. Drug Metab. Rev.39(1),45–60 (2007).
- 16 Schaeffeler E, Schwab M, Eichelbaum M, Zanger UM: CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCR. Hum. Mutat.22(6),476–485 (2003).
- 17 Hosono N, Kato M, Kiyotani K et al.: CYP2D6 genotyping for functional-gene dosage analysis by allele copy number detection. Clin. Chem.55(8),1546–1554 (2009).
- 18 Strobietto HL, Leeder JS, Gaedigk A: Simultaneous detection of CYP2D6, SULT1A1 and UGT2B17 copy number variation (CNV) by multiplex PCR. Presented at: American Society of Clinical Pharmacology and Therapeutics. Atlanta, GA, USA, March 17–20, 2010.
- 19 Ramamoorthy A, Flockhart DA, Hosono N, Kubo M, Nakamura Y, Skaar TC: Differential quantification of CYP2D6 gene copy number by four different quantitative real-time PCR assays. Pharmacogenet. Genomics20(7),451–454 (2010).
- 20 Craddock N, Hurles ME, Cardin N et al.: Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature464(7289),713–720 (2010).
- 101 Indiana University; Division of Clinical Pharmacology: P450 Drug Interaction Table http://medicine.iupui.edu/clinpharm/ddis/table.asp
- 102 CYP2D6 allele nomenclature www.cypalleles.ki.se/cyp2d6.htm